BioSpace News Archive

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced the enrollment of adult patients for its Phase II trial for merimepodib, a broad-spectrum, orally administered antiviral drug candidate for the treatment of COVID-19, at four key trial sites.

We were originally going to make this announcement in March, but as you all are well aware, we were forced to turn our attention to addressing the public health emergency posed by the COVID-19 pandemic.

Radianse, intelligent solutions and internet of Things (IoT) expert, is proud to announce their task-scheduling and management software that connects the physical and digital environments for businesses of all types.

Invacare Corporation (NYSE: IVC) and Alber®, a global leader in power-assist solutions, announced today the US introduction of SMOOV one™, an innovative and pioneering power-assist solution aiding manual wheelchair users.